- Blink Pharma, the leading platform for managing transactions between healthcare professionals, has successfully completed its first round with the Azur Innovation Fund Investment Fund to fund the development of its operations, including the launch of new products for the healthcare sector.
- Morocco-based healthtech Blink Pharma has raised investment from Azur Innovation Fund for an undisclosed amount.
- Launched in 2020 by Ali Sami and Adil Bertul, the B2B marketplace allows pharmacists, laboratories and wholesalers to exchange orders, as well as providing them with a payment method.
- The new funding will help Blink Pharma develop its operations, including the launch of new products for the healthcare sector.
With a digital solution to streamline transactions between healthcare professionals (laboratories, wholesalers and pharmacists) to avoid bottlenecks, late deliveries or simply degraded service quality, startup Blink Pharma has raised funds for the first time with the Azur Innovation Fund.
In fact, in 2020 the startup launched its marketplace, which not only allows to transmit orders from pharmacists to laboratories and wholesalers but also to carry out the commercial transaction thanks to a system that complies with Law 17-04. The platform also offers a news and information section and already has a network of more than 3,500 pharmacists subscribing to the service.
In addition to this flagship product, Blink Pharma is developing other digital products that offer real solutions for healthcare professionals. These solutions are a response to barriers identified in this area by building on the expertise of Founding Directors Ali Sami CEO and Adil Bertul CCO in this area.
“We have the ambition to accelerate the digital footprint around healthcare services. We started our journey with the pharmacy to expand our services to the doctor and the patient. The healthcare sector is being profoundly transformed by digital technology and we want to support healthcare stakeholders in this transformation. We benefit from our in-depth knowledge of the scientific and regulatory environment. Still, as we come from the healthcare sector, we also have great respect for the ethical rules of the sector. »
“More applications are in the pipeline, always aiming to support healthcare professionals, we are proud to have convinced a major investment fund like Azur Innovation Fund, allowing us to realise the full potential of digitization in healthcare,” Ali Sami, CEO of Blink Pharma.
The Azur Innovation Fund is a Moroccan seed fund at the service of the Moroccan startup that aims to maximize the value for all stakeholders of the projects funded: shareholders, promoters, collaborators, industrial ecosystem, communities… This is done through a smart capital enables approach that combines funding, mentoring, technical support and monitoring.
Source: News Beezer